N@N

OFIX, LIFE, VPHM, QSII, HL, SHPGY Expected To Be Up After Next Earnings Releases

^{Published on 2011-07-27 07:00:55 - WOPRAI}
 

July 27, 2011 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Thursday, July 28th 2011 and determining how the stocks have performed After their last 12 quarterly, 6 quarterly and December earnings reports. ORTHOFIX INTERNATIONAL NV (NASDAQ:OFIX), LIFE TECHNOLOGIES CORP (NASDAQ:LIFE), VIROPHARMA INC (NASDAQ:VPHM), QUALITY SYSTEMS INC (NASDAQ:QSII), HECLA MINING CO (NYSE:HL), SHIRE PLC-ADR (NASDAQ:SHPGY) are all expected to be Up After their earnings are released. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go Up After earnings are released Thursday:

     Symbol     Company                             # of Reports            Quarter     Release Time
     OFIX       ORTHOFIX INTERNATIONAL NV           12 Quarter              Q2          After
     LIFE       LIFE TECHNOLOGIES CORP              6 Quarter               Q2          Before
     VPHM       VIROPHARMA INC                      6 Quarter               Q2          Before
     QSII       QUALITY SYSTEMS INC                 6 Quarter               Q1          Before
     HL         HECLA MINING CO                     July Earnings           Q2          Before
     SHPGY      SHIRE PLC-ADR                       12 Quarter              Q2          Before

ORTHOFIX INTERNATIONAL NV (NASDAQ:OFIX) - Orthofix International N.V. designs, develops, manufactures, markets, and distributes medical equipment, principally for the orthopedic applications. Its products include invasive and minimally invasive spinal implant products, and related human cellular and tissue based products; non-invasive bone growth stimulation products for spinal fusions and to treat non-union fractures; external and internal fixation devices used in fracture treatment, limb lengthening, and bone reconstruction; and bracing products used for ligament injury prevention, pain management, and protection of surgical repair. The companys products also comprise a device for enhancing venous circulation, cold therapy, bone cement and devices for removal of bone cement used to fix artificial implants, and airway management products used in anesthesia applications. It provides its products for the spine, orthopedics, sports medicine, and vascular market sectors serving hospitals, clinics, surgery centers, independent distributors or other healthcare providers, and patients by third-party payors. Orthofix International distributes its products in the United States, the United Kingdom, Italy, Germany, Switzerland, Austria, France, Belgium, Mexico, Brazil, and Puerto Rico through its direct sales representatives and independent distributors. The company was founded in 1979 and is based in Curacao, the Netherlands Antilles.

LIFE TECHNOLOGIES CORP (NASDAQ:LIFE) - Life Technologies Corporation operates as a life sciences company with a focus on improving the human condition worldwide. Its systems, consumables, and services enable scientific researchers and commercial markets to accelerate scientific exploration, leading to discoveries and developments that better the quality of life. Life Technologies customers work across the biological spectrum, advancing genomic medicine, regenerative science, molecular diagnostics, agricultural and environmental research, and 21st century forensics. The company delivers a range of products and services, including systems, instruments, reagents, software, and custom services. Its product portfolio comprises technologies for PCR, sample preparation, cell culture, RNA interference analysis, functional genomics research, proteomics and cell biology applications, capillary electrophoresis based sequencing, and next generation sequencing, as well as clinical diagnostic applications, forensics, animal, food, pharmaceutical, and water testing analysis. The company has a presence in approximately 160 countries, and possesses an intellectual property estate of approximately 4,000 patents and exclusive licenses. Life Technologies was created by the combination of Invitrogen Corporation and Applied Biosystems, Inc. The company is based in Carlsbad, California.

VIROPHARMA INC (NASDAQ:VPHM) - ViroPharma Incorporated, a biopharmaceutical company, engages in the development and commercialization of products that address serious diseases with a focus on products used by physician specialists or in hospital settings in the United States and internationally. The companys product line includes Cinryze for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema; and Vancocin HCl capsules for the treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile infection and enterocolitis caused by Staphylococcus aureus, including methicillin-resistant strains. Its products in development include C1 esterase inhibitor to identify further therapeutic uses and potential additional indications and other modes of administration for the treatment of HAE and other C1 mediated diseases; a non-toxigenic strain of C. difficile for the treatment and prevention of CDI.; and Maribavir, which is in Phase III clinical development stage for the prevention and treatment of cytomegalovirus infections related to transplant. The company sells its products directly to wholesale drug distributors, and specialty pharmacies/specialty distributors. ViroPharma Incorporated was founded in 1994 and is headquartered in Exton, Pennsylvania.

QUALITY SYSTEMS INC (NASDAQ:QSII) - Quality Systems Inc. and its subsidiary NextGen Healthcare Information Systems Inc. develop and market health-care information systems that automate medical and dental practices for physician hospital and management service organizations, ambulatory care centers, community health centers, and medical and dental schools. The company, based in Irvine, Calif., offers proprietary software under the NextGen3 name for keeping medical records (NextGenemr) and managing a medical practice (NextGenepm). Other NextGen software handles appointment scheduling, keeps a master patient index, and operates such devices as an image control system, a managed care server, an Internet-based data interchange with system interfaces, and a patient-centric and provider-centric Web portal solution. The company also provides NextGen Express for small practices, and NextGen Community Health Solution. In addition, Quality Systems offers hardware and software maintenance and support services, system training services, and electronic data interchange services, which connect patients, providers, and payers in various ways. Quality Systems was founded in 1974.

HECLA MINING CO (NYSE:HL) - Hecla Mining Company engages in the discovery, acquisition, development, production, and marketing of silver, gold, lead, and zinc. It owns a 100% interest in the Lucky Friday unit located in northern Idaho; and a 100% interest in the Greens Creek unit located on Admiralty Island, near Juneau, Alaska. The company produces and sells lead, zinc, and bulk concentrates to custom smelters on contract; and unrefined silver and gold bullion bars to precious metals traders. Hecla Mining Company was founded in 1891 and is headquartered in Coeur dAlene, Idaho.

SHIRE PLC-ADR (NASDAQ:SHPGY) - Shire plc, a specialty biopharmaceutical company, engages in the research and development, manufacture, sale, and distribution of pharmaceutical products. It operates in two segments, Specialty Pharmaceuticals and Human Genetic Therapies. The Specialty Pharmaceuticals segment offers products for the treatment of attention deficit and hyperactivity disorder, including VYVANSE, a pro-drug stimulant; INTUNIV, an alpha-2A receptor; EQUASYM; and ADDERALL XR. It also produces PENTASA and LIALDA/MEZAVANT for the treatment of active ulcerative colitis; and RESOLOR, which is 5-HT4 receptor agonist that stimulates gastrointestinal motility. In addition, this segment provides FOSRENOL for use in end-stage renal failure patients receiving dialysis; CALCICHEW, a range of calcium and calcium/vitamin D3 supplements; CARBATROL, an anti-convulsant for individuals with epilepsy; REMINYL/REMINYL XL for the symptomatic treatment of dementia of the Alzheimer type; and XAGRID for the reduction of elevated platelet counts, as well as for the treatment of thrombocythemia. The Human Genetic Therapies segment offers REPLAGAL for Fabry disease; ELAPRASE for the treatment of hunter syndrome; FIRAZYR for hereditary angioedema; and VPRIV for the treatment of type 1 Gaucher disease. The company also licenses its patented antiviral products for human immunodeficiency virus and Hepatitis B. In addition, it is developing various products in the areas of attention deficit hyperactivity disorder, human genetic therapies, and gastrointestinal diseases, as well as in other therapeutic areas. The company markets its products through distributors in North America, the Republic of Ireland, the United Kingdom, and internationally. It has collaboration agreements with Santaris Pharma A/S, Renovo Limited, and Acceleron Pharma, Inc. Shire plc was founded in 1986 and is based in Dublin, Ireland.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641